inical And Laboratory Results Of Intrauterine Device Cu T 380 A Intrauterine System Intraoperative Injection
Nasirova Zebiniso Azizovna , Samarkand State Medical Institute, Samarkand, Uzbekistan Negmadjanov Bahodur Boltaevich , Samarkand State Medical Institute, Samarkand, UzbekistanAbstract
Effective and safe contraceptive methods not only prevent unplanned pregnancies and their
termination, but also make it possible to fully restore the mother's body after surgery to carry out the
necessary pre-pregnancy preparation. The goal of the study was to evaluate the clinical outcome of
postplacental administration of Cu T 380 A in women during a caesarean section. The study was
conducted at Samarkand Maternity Hospital No. 2 to assess the clinical outcome of postplacental
administration of Cu T 380 A in women during caesarean section. The present study showed that there
were no serious complications and only minor side effects such as pain, fever, bleeding and irregular
bleeding, which were observed only in some women during the hospital stay and the control visit in
the first 6 months. The determination of vaginal BMW tendrils was made possible in 72.12% of women
during the control visit after 6 weeks. The visibility of the tendrils increased over time and after 6
months they were seen in 90.81% of cases. Exposure frequency was 2 cases (4%) and another 2 women
(4%) required removal of the PMTCT for various reasons, resulting in a 92.3% retention rate six months
after contraception. No cases of pregnancy were registered. Post-placental introduction of BIC Cu T
380 A during a C-section is a practical, convenient, safe, effective and acceptable contraceptive
method.
Keywords
Сlinical results,, BIC Cu T 380 A
References
An A.V., Pakhomova J.E., Maternal lethality
after Caesarean section. Problems of
Reproduction No. 3, 2010; pp.83-86.
Ayupova F.M., Khamdamova M.T. Clinical
aspects of the use of copper-containing
intrauterine devices // Uzbekiston Tibbiet
Journalist. -2010. № 6. 59-64.
Dikke G.B. LARC-methods of first choice in
prevention of unwanted pregnancy and
repeated abortion // Pharmatek. 2013. №.
p. 8-13.
Barbosa RM, et al. Differences in the
Access to Sterilization between Women
Living and Not Living with HIV: Results
from the GENIH Study, Brazil PLoS One
Brunson M. R. et al. Postpartum
contraception: and effectiveness in a large
universal healthcare system //American
journal of obstetrics and gynecology. 2017.
Т. 217. №. 1. Pp. 55. e1-55. e9.
Garcia G. et al. Trends and disparities in
postpartum sterilization after cesarean
section, 2000 through 2008 //Women's
Health Issues. 2015. Т. 25. №. 6. p. 634-640.
Goldthwaite LM, et al. Postpartum
intrauterine devices: clinical and
programmatic review Am J Obstet Gynecol
- Review.
Haider S. et al. A Novel Approach to
Postpartum Contraception Provision
Combined with Infant Care: A Randomized,
Controlled Trial //Women's Health Issues.
Т. 30. №. 2. p. 83-92
Article Statistics
Copyright License
Copyright (c) 2020 The American Journal of Medical Sciences and Pharmaceutical Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.